https://www.selleckchem.com/pr....oducts/Temsirolimus.
Introduction Polymer-free drug-eluting stents are designed with stent surface modifications and drug-matrix formulations in order to release antiproliferative agents without the need of a polymer coating. Polymer-free technologies have the potential to overcome complications due to polymer persistence over time, such as local inflammatory reactions, delayed arterial healing, neoatherosclerosis, and subsequent ischemic adverse events.Areas covered The Cre8 polymer-free amphilimus-eluting stent received CE mark in 2011 and was concei
Curtir
Comentario
Compartilhar
